Bay City Capital Fund V Co-Investment Fund, L.P.
Insider CIK 1409813 · ILIU 10% owner · SNSS 10% owner · HPTX 10% owner · DERM 10% owner · EPZM 10% owner · IMRA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IMRA IMARA Inc. | A Award deriv | 2020-03-16 | 2020-03-16 | 15,457 | — | $0 | 15,457 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 61,378 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 845,008 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 281,878 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 5,372 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 3,220,915 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 16,103 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 281,878 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 5,372 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 3,220,915 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 61,378 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 845,008 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | C Conversion deriv | 2020-03-16 | 2020-03-16 | 16,103 | — | $0 | 0 | SEC↗ |
| IMRA IMARA Inc. | A Award deriv | 2020-03-16 | 2020-03-16 | 15,457 | — | $0 | 15,457 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 13,148 | — | $0 | 703,380 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 690,232 | — | $0 | 690,232 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 13,148 | — | $0 | 703,380 | SEC↗ |
| IMRA IMARA Inc. | C Conversion | 2020-03-16 | 2020-03-16 | 690,232 | — | $0 | 690,232 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy deriv | 2016-07-29 | 2016-08-02 | 29,616,700 | — | $0 | 29,616,700 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy deriv | 2016-07-29 | 2016-08-02 | 564,386 | — | $0 | 564,386 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy | 2016-07-29 | 2016-08-02 | 564,386 | $0.10 | $56.4K | 1,444,485 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy | 2016-07-29 | 2016-08-02 | 29,616,700 | $0.10 | $2.96M | 75,800,716 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2016-01-12 | 2016-01-12 | 545,166 | $9.00 | $4.91M | 3,370,562 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2016-01-12 | 2016-01-12 | 10,389 | $9.00 | $93.5K | 3,380,951 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise deriv | 2015-07-24 | 2015-07-28 | 10,383 | — | $0 | 0 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise deriv | 2015-07-24 | 2015-07-28 | 1,089,788 | — | $0 | 0 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise deriv | 2015-07-24 | 2015-07-28 | 20,766 | — | $0 | 0 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise deriv | 2015-07-24 | 2015-07-28 | 544,893 | — | $0 | 0 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2015-07-24 | 2015-07-28 | 415,877 | $3.46 | $1.44M | 5,267,598 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2015-07-24 | 2015-07-28 | 3,962 | $3.46 | $13.7K | 5,623,815 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise | 2015-07-24 | 2015-07-28 | 1,089,788 | $1.32 | $1.44M | 5,683,475 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2015-07-24 | 2015-07-28 | 7,925 | $3.46 | $27.4K | 5,617,394 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise | 2015-07-24 | 2015-07-28 | 10,383 | $1.32 | $13.7K | 5,627,777 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2015-07-24 | 2015-07-28 | 207,938 | $3.46 | $719.5K | 5,604,553 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise | 2015-07-24 | 2015-07-28 | 544,893 | $1.32 | $719.3K | 5,812,491 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | X Exercise | 2015-07-24 | 2015-07-28 | 20,766 | $1.32 | $27.4K | 5,625,319 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy deriv | 2014-12-23 | 2014-12-24 | 25,996,552 | — | $0 | 25,996,552 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy deriv | 2014-12-23 | 2014-12-24 | 495,400 | — | $0 | 495,400 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy | 2014-12-23 | 2014-12-24 | 25,996,552 | $0.10 | $2.60M | 46,184,016 | SEC↗ |
| ILIU INTERLEUKIN GENETICS INC | P Buy | 2014-12-23 | 2014-12-24 | 495,400 | $0.10 | $49.5K | 880,099 | SEC↗ |
| DERM Dermira, Inc. | C Conversion deriv | 2014-10-08 | 2014-10-08 | 375,681 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | C Conversion deriv | 2014-10-08 | 2014-10-08 | 7,159 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | C Conversion deriv | 2014-10-08 | 2014-10-08 | 2,337,590 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | C Conversion deriv | 2014-10-08 | 2014-10-08 | 44,545 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | C Conversion deriv | 2014-10-08 | 2014-10-08 | 643,066 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | C Conversion deriv | 2014-10-08 | 2014-10-08 | 12,254 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | P Buy | 2014-10-08 | 2014-10-08 | 67,820 | $16.00 | $1.09M | 3,441,075 | SEC↗ |
| DERM Dermira, Inc. | P Buy | 2014-10-08 | 2014-10-08 | 1,292 | $16.00 | $20.7K | 65,572 | SEC↗ |
| DERM Dermira, Inc. | C Conversion | 2014-10-08 | 2014-10-08 | 63,958 | — | $0 | 64,280 | SEC↗ |
| DERM Dermira, Inc. | C Conversion | 2014-10-08 | 2014-10-08 | 3,356,337 | — | $0 | 3,373,255 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-28 | 2014-08-29 | 196,260 | $7.89 | $1.55M | 4,597,427 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-28 | 2014-08-29 | 3,740 | $7.89 | $29.5K | 4,593,687 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-27 | 2014-08-29 | 98,817 | $8.16 | $806.3K | 4,795,570 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-27 | 2014-08-29 | 1,883 | $8.16 | $15.4K | 4,793,687 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-26 | 2014-08-28 | 196,260 | $35.14 | $6.90M | 2,829,136 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-26 | 2014-08-28 | 3,740 | $35.14 | $131.4K | 2,825,396 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-25 | 2014-08-25 | 17 | $36.40 | $619 | 2,825,396 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-25 | 2014-08-25 | 883 | $36.40 | $32.1K | 2,825,413 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-25 | 2014-08-25 | 3,723 | $35.13 | $130.8K | 2,826,296 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-25 | 2014-08-25 | 195,377 | $35.13 | $6.86M | 2,830,019 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-22 | 2014-08-25 | 125,606 | $32.46 | $4.08M | 3,027,790 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-22 | 2014-08-25 | 2,394 | $32.46 | $77.7K | 3,025,396 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-21 | 2014-08-25 | 723 | $33.04 | $23.9K | 3,153,396 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-08-21 | 2014-08-25 | 37,943 | $33.04 | $1.25M | 3,154,119 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-12 | 2014-08-12 | 694 | $6.77 | $4.7K | 4,894,387 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-12 | 2014-08-12 | 36,406 | $6.77 | $246.5K | 4,895,081 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-11 | 2014-08-12 | 31,009 | $6.90 | $214.0K | 4,932,078 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-11 | 2014-08-12 | 591 | $6.90 | $4.1K | 4,931,487 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-08 | 2014-08-12 | 12,622 | $6.62 | $83.6K | 4,963,087 | SEC↗ |
| SNSS SUNESIS PHARMACEUTICALS IN | S Sale | 2014-08-08 | 2014-08-12 | 662,378 | $6.62 | $4.38M | 4,975,709 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-02-10 | 2014-02-12 | 8,727 | $29.25 | $255.3K | 3,192,062 | SEC↗ |
| EPZM Epizyme, Inc. | S Sale | 2014-02-10 | 2014-02-12 | 457,940 | $29.25 | $13.39M | 3,200,789 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-10-18 | 2013-10-21 | 3,740 | $26.00 | $97.2K | 35,820 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-10-18 | 2013-10-21 | 196,260 | $26.00 | $5.10M | 1,879,836 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-19 | 2013-07-19 | 5,103 | $26.69 | $136.2K | 2,076,096 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-19 | 2013-07-19 | 97 | $26.69 | $2.6K | 39,560 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-18 | 2013-07-19 | 3,634 | $26.00 | $94.5K | 2,081,199 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-18 | 2013-07-19 | 69 | $26.00 | $1.8K | 39,657 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-17 | 2013-07-19 | 1,627 | $26.00 | $42.3K | 39,726 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-17 | 2013-07-19 | 85,373 | $26.00 | $2.22M | 2,084,833 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-10 | 2013-07-11 | 50,861 | $22.35 | $1.14M | 2,172,856 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-10 | 2013-07-11 | 969 | $22.35 | $21.7K | 41,403 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-10 | 2013-07-19 | 50,861 | $22.35 | $1.14M | 2,170,206 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-10 | 2013-07-19 | 969 | $22.35 | $21.7K | 41,353 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-09 | 2013-07-11 | 1,079 | $22.50 | $24.3K | 2,223,717 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-09 | 2013-07-11 | 21 | $22.50 | $473 | 42,372 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-09 | 2013-07-19 | 1,079 | $22.50 | $24.3K | 2,221,067 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-09 | 2013-07-19 | 21 | $22.50 | $473 | 42,322 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-08 | 2013-07-08 | 166 | $22.50 | $3.7K | 42,393 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-08 | 2013-07-08 | 8,734 | $22.50 | $196.5K | 2,224,796 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-08 | 2013-07-19 | 166 | $22.50 | $3.7K | 42,343 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-08 | 2013-07-19 | 8,734 | $22.50 | $196.5K | 2,222,146 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-05 | 2013-07-08 | 2 | $22.50 | $45 | 42,559 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-05 | 2013-07-08 | 98 | $22.50 | $2.2K | 2,233,530 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-05 | 2013-07-19 | 2,748 | $22.50 | $61.8K | 2,230,880 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-05 | 2013-07-19 | 52 | $22.50 | $1.2K | 42,509 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-03 | 2013-07-08 | 249 | $22.50 | $5.6K | 42,561 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-07-03 | 2013-07-08 | 13,051 | $22.50 | $293.6K | 2,233,628 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-06-28 | 2013-07-01 | 297 | $22.51 | $6.7K | 42,810 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-06-28 | 2013-07-01 | 15,563 | $22.51 | $350.3K | 2,246,679 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-06-27 | 2013-07-01 | 9,813 | $22.53 | $221.1K | 2,262,242 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-06-27 | 2013-07-01 | 187 | $22.53 | $4.2K | 43,107 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2013-06-05 | 2013-06-07 | 17,666 | — | $0 | 17,666 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion deriv | 2013-06-05 | 2013-06-07 | 195,904 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion deriv | 2013-06-05 | 2013-06-07 | 10,280,288 | — | $0 | 0 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion | 2013-06-05 | 2013-06-07 | 65,301 | — | $0 | 3,492,063 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2013-06-05 | 2013-06-07 | 163,549 | $15.00 | $2.45M | 3,655,612 | SEC↗ |
| EPZM Epizyme, Inc. | P Buy | 2013-06-05 | 2013-06-07 | 3,117 | $15.00 | $46.8K | 3,658,729 | SEC↗ |
| EPZM Epizyme, Inc. | C Conversion | 2013-06-05 | 2013-06-07 | 3,426,762 | — | $0 | 3,426,762 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | S Sale | 2013-05-30 | 2013-05-30 | 5,266 | $21.00 | $110.6K | 2,260,990 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | S Sale | 2013-05-30 | 2013-05-30 | 100 | $21.00 | $2.1K | 43,083 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | S Sale | 2013-05-28 | 2013-05-30 | 224 | $21.08 | $4.7K | 43,183 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | S Sale | 2013-05-28 | 2013-05-30 | 11,776 | $21.08 | $248.2K | 2,266,256 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise deriv | 2013-05-23 | 2013-05-31 | 2,098 | — | $0 | 8,967 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise deriv | 2013-05-23 | 2013-05-31 | 40 | — | $0 | 171 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise deriv | 2013-05-23 | 2013-05-31 | 8,967 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise deriv | 2013-05-23 | 2013-05-31 | 171 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-05-23 | 2013-05-31 | 2,098 | $7.31 | $15.3K | 2,263,088 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-05-23 | 2013-05-31 | 40 | $7.31 | $292 | 43,123 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-05-23 | 2013-05-31 | 8,967 | $4.08 | $36.6K | 2,272,055 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2013-05-23 | 2013-05-31 | 171 | $4.08 | $698 | 43,294 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | S Sale | 2013-05-20 | 2013-05-21 | 37 | $22.24 | $823 | 43,407 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | S Sale | 2013-05-20 | 2013-05-21 | 1,963 | $22.24 | $43.7K | 2,278,032 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | S Sale | 2013-05-17 | 2013-05-21 | 2,421 | $22.69 | $54.9K | 43,444 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | S Sale | 2013-05-17 | 2013-05-21 | 127,034 | $22.69 | $2.88M | 2,279,995 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 23,320 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion deriv | 2012-07-31 | 2012-08-02 | 1,223,794 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | J Other deriv | 2012-07-31 | 2012-08-02 | 62 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | J Other deriv | 2012-07-31 | 2012-08-02 | 3,312 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise deriv | 2012-07-31 | 2012-08-02 | 1,144 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise deriv | 2012-07-31 | 2012-08-02 | 60,114 | — | $0 | 0 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 143,842 | $10.00 | $1.44M | 2,470,029 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 6,704 | $10.00 | $67.0K | 40,337 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 2,787 | $10.00 | $27.9K | 43,124 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 2,741 | $10.00 | $27.4K | 45,865 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award | 2012-07-31 | 2012-08-02 | 477,893 | $10.00 | $4.78M | 477,893 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | A Award | 2012-07-31 | 2012-08-02 | 9,107 | $10.00 | $91.1K | 9,107 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 146,255 | $10.00 | $1.46M | 2,263,187 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 351,819 | $10.00 | $3.52M | 2,116,932 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | J Other | 2012-07-31 | 2012-08-02 | 62 | — | $0 | 33,633 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | J Other | 2012-07-31 | 2012-08-02 | 3,312 | — | $0 | 1,765,113 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2012-07-31 | 2012-08-02 | 1,144 | — | $0 | 33,571 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | X Exercise | 2012-07-31 | 2012-08-02 | 60,114 | — | $0 | 1,761,801 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 23,320 | — | $0 | 32,427 | SEC↗ |
| HPTX HYPERION THERAPEUTICS INC | C Conversion | 2012-07-31 | 2012-08-02 | 1,223,794 | — | $0 | 1,701,687 | SEC↗ |